Lilly's Evista gets Fda Ok for breast cancer
Lilly's Evista gets Fda Ok for breast cancer "Further, postmenopausal women
at high risk for invasive breast cancer will have an alternative therapy for
invasive breast cancer risk reduction". FDA says Eli Lilly and Co.
osteoporosis drug reduces risk of invasive breast cancer in ...
http://www.topix.com/business/biotech/2007/09/lillys-evista-gets-fda-ok-for
-breast-cancer?fromrss=1
Biotech News
http://www.topix.com/business/biotech
Biotech News
AZhttp, Inc.
Biotechnology Marketing
at high risk for invasive breast cancer will have an alternative therapy for
invasive breast cancer risk reduction". FDA says Eli Lilly and Co.
osteoporosis drug reduces risk of invasive breast cancer in ...
http://www.topix.com/business/biotech/2007/09/lillys-evista-gets-fda-ok-for
-breast-cancer?fromrss=1
Biotech News
http://www.topix.com/business/biotech
Biotech News
AZhttp, Inc.
Biotechnology Marketing



0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home